PROTHERAGEN.COM: Keyword Density Checker

Total words: 1453 | 2-word phrases: 369 | 3-word phrases: 410 | 4-word phrases: 422

PAGE INFO

Title	Try to keep the title under 60 characters (18 characters) Home - Protheragen
Description	Try to keep the meta description between 50 - 160 characters (11 characters) Protheragen
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (11 characters) Protheragen

#	Keyword	Frequency	Density
1	solid tumor	7	1.90%
2	intermediary service	4	1.08%
3	multiple myeloma	4	1.08%
4	available projects	3	0.81%
5	equity investment	3	0.81%
6	about us	3	0.81%
7	glp1 analogue	3	0.81%
8	pdl1 ovfv01	2	0.54%
9	after founded	2	0.54%
10	iia inhibitors	2	0.54%
11	nmmhc iia	2	0.54%
12	founded in	2	0.54%
13	new york	2	0.54%
14	fascin inhibitor	2	0.54%
15	in new	2	0.54%
16	rapidly after	2	0.54%
17	compound 4	2	0.54%
18	polyoxygenated cyclohexene	2	0.54%
19	york our	2	0.54%
20	molecules ivw1001	2	0.54%

#	Keyword	Frequency	Density
1	from the initial	2	0.49%
2	careers contact us	2	0.49%
3	to encompass segments	2	0.49%
4	recombinant protein therapy	2	0.49%
5	protein therapy p75neuro	2	0.49%
6	service to encompass	2	0.49%
7	intermediary service to	2	0.49%
8	ultralongacting glp1 analogue	2	0.49%
9	initial intermediary service	2	0.49%
10	the initial intermediary	2	0.49%
11	our business has	2	0.49%
12	growing rapidly after	2	0.49%
13	york our business	2	0.49%
14	new york our	2	0.49%
15	in new york	2	0.49%
16	founded in new	2	0.49%
17	small molecules ivw1001	2	0.49%
18	after founded in	2	0.49%
19	rapidly after founded	2	0.49%
20	polyoxygenated cyclohexene compound	2	0.49%
21	encompass segments in	2	0.49%
22	cyclohexene compound 4	2	0.49%
23	type 2 diabetes	2	0.49%
24	and program incubation	2	0.49%
25	solid tumor pd1	2	0.49%
26	tumor pd1 and	2	0.49%
27	project incubation service	2	0.49%
28	therapy antibody product	2	0.49%
29	glp1 analogue a	2	0.49%
30	cell multiple myeloma	2	0.49%

#	Keyword	Frequency	Density
1	the initial intermediary service	2	0.47%
2	new york our business	2	0.47%
3	in new york our	2	0.47%
4	founded in new york	2	0.47%
5	from the initial intermediary	2	0.47%
6	after founded in new	2	0.47%
7	recombinant protein therapy p75neuro	2	0.47%
8	initial intermediary service to	2	0.47%
9	intermediary service to encompass	2	0.47%
10	service to encompass segments	2	0.47%
11	to encompass segments in	2	0.47%
12	rapidly after founded in	2	0.47%
13	growing rapidly after founded	2	0.47%
14	investment and program incubation	2	0.47%
15	york our business has	2	0.47%
16	ultralongacting glp1 analogue a	2	0.47%
17	solid tumor pd1 and	2	0.47%
18	polyoxygenated cyclohexene compound 4	2	0.47%
19	il15 oncolytic virotherapy rvscfvpdl1	1	0.24%
20	receptor angiocidin acute myeloid	1	0.24%
21	angiocidin acute myeloid leukemia	1	0.24%
22	death receptor 6 tt173	1	0.24%
23	receptor 6 tt173 surgical	1	0.24%
24	6 tt173 surgical bleeding	1	0.24%
25	surgical bleeding and trauma	1	0.24%
26	tt173 surgical bleeding and	1	0.24%
27	tumor il15 oncolytic virotherapy	1	0.24%
28	bleeding and trauma biolink001	1	0.24%
29	and trauma biolink001 solid	1	0.24%
30	rvscfvpdl1 cancer pdl1 ovfv01	1	0.24%
31	virotherapy rvscfvpdl1 cancer pdl1	1	0.24%
32	oncolytic virotherapy rvscfvpdl1 cancer	1	0.24%
33	home available projects overview	1	0.24%
34	cancer pdl1 ovfv01 cancer	1	0.24%
35	4 pain nav17 ppm100	1	0.24%
36	sirt1 nmmhc iia inhibitors	1	0.24%
37	disease sirt1 nmmhc iia	1	0.24%
38	alzheimer’s disease sirt1 nmmhc	1	0.24%
39	cancer fascin resveratrol micellar	1	0.24%
40	inhibitor cancer fascin resveratrol	1	0.24%

#	URL	Whois	Check
1	https://www.linkedin.com/company/protheragen-inc-/	Whois	linkedin.com
2	https://www.facebook.com/protheragen/	Whois	facebook.com
3	https://twitter.com/ProtheragenInc	Whois	twitter.com
4	https://www.instagram.com/protheragen/	Whois	instagram.com